Research & Development: This Technical Area concentrates on company efforts (both in-house and through collaboration) to develop new or adapted remedies for high priority diseases in the Index Countries where there is a research need and a market failure. It also captures any controversies related to clinical trials and the company's approach to monitoring ethical standards. The impact of intellectual capital sharing and licencing details pertaining to collaborative research and development is also highlighted.